Cart
sales@molnova.com
Ly-295501
CAS No. 150869-74-2
Ly-295501( —— )
Catalog No. M36191 CAS No. 150869-74-2
Ly-295501 (ILX-295501) showed antitumor and anticancer activity in human pancreatic cancer xenotransplantation model.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 114 | Get Quote |
|
| 5MG | 170 | Get Quote |
|
| 10MG | 257 | Get Quote |
|
| 25MG | 466 | Get Quote |
|
| 50MG | 626 | Get Quote |
|
| 100MG | 891 | Get Quote |
|
| 500MG | 1782 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLy-295501
-
NoteResearch use only, not for human use.
-
Brief DescriptionLy-295501 (ILX-295501) showed antitumor and anticancer activity in human pancreatic cancer xenotransplantation model.
-
DescriptionLy-295501 (ILX-295501) showed antitumor and anticancer activity in human pancreatic cancer xenotransplantation model.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number150869-74-2
-
Formula Weight387.24
-
Molecular FormulaC15H12Cl2N2O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(NC(NC1=CC(Cl)=C(Cl)C=C1)=O)(=O)(=O)C=2C=C3C(=CC2)OCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Itolizumab
Itolizumab (Anti-Human CD6 Recombinant Antibody) is a recombinant anti-CD6 monoclonal antibody that targets the extracellular SRCR distal domain 1 of CD6, thereby slowing T cell proliferation and inhibiting pro-inflammatory cytokine production.
-
NFATc1-IN-1
NFATc1-IN-1 (also known as compound A04) is a highly effective inhibitor of osteoclast formation induced by RANKL, with an IC50 of 1.57 μM.
-
15-O-Methylgracilifl...
15-O-Methylgraciliflorin F
